Unraveling the Transcriptomic Signatures of Homologous Recombination Deficiency in Ovarian Cancers-Reference-Cited by-同舟云学术

Unraveling the Transcriptomic Signatures of Homologous Recombination Deficiency in Ovarian Cancers

Published:2022-09-18 Issue:12 Volume:6 Page:2200060
ISSN:2701-0198
Container-title:Advanced Biology
language:en
Short-container-title:Advanced Biology

Author:

Lee Jae Jun¹²,Kang Hyun Ju¹³,Kim Stephanie S.²,Charton Clémentine²,Kim Jinho²,Lee Jin‐Ku¹³⁴^ORCID

Affiliation:

1. Medical Research Center Genomic Medicine Institute Seoul National University College of Medicine Seoul 03080 Republic of Korea

2. Precision Medicine Center Future Innovation Research Division Seoul National University Bundang Hospital Seongnam Gyeonggi‐do 13620 Republic of Korea

3. Department of Biomedical Sciences Seoul National University College of Medicine Seoul 03080 Republic of Korea

4. Department of Anatomy and Cell Biology Seoul National University College of Medicine Seoul 03080 Republic of Korea

Funder

National Research Foundation of Korea

National Cancer Center

Ministry of Food and Drug Safety

Publisher

Wiley

Subject

General Biochemistry, Genetics and Molecular Biology,Biomedical Engineering,Biomaterials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adbi.202200060

Reference55 articles.

1. Mechanisms of DNA damage, repair, and mutagenesis

2. Endogenous DNA Damage as a Source of Genomic Instability in Cancer

3. DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells

4. Mechanism of Eukaryotic Homologous Recombination

5. Pan-cancer landscape of homologous recombination deficiency

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. expHRD: an individualized, transcriptome-based prediction model for homologous recombination deficiency assessment in cancer;BMC Bioinformatics;2024-07-12

2. Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities;npj Precision Oncology;2024-03-13

3. Association between Homologous Recombination Repair Defect Status and Long-Term Prognosis of Early HER2-Low Breast Cancer: A Retrospective Cohort Study;The Oncologist;2024-02-16